Benefit‐risk Assessment of Investigational Drugs: Current Methodology, Limitations, and Alternative Approaches

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Pharmacotherapy

• Publication date

  1986-11-12

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/j.1875-9114.1986.tb03491.xPMID 3547349
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thiazide diuretics, hypokalemia and cardiac arrhythmias.

  2009cited by this paper
• Differences in the response of hepatic and intestinal drug metabolizing enzymes in rats following carbon tetrachloride and/or phenobarbital treatment.

  2009cited by this paper
• Preclinical toxicological testing and safeguards in clinical trials

  2004cited by this paper
• Innovation and Evaluation : Science

  1987cited by this paper
• Determining optimal therapy--randomized trials in individual patients.

  1986cited by this paper
• Mortality and Morbidity Results from the European Working Party on High Blood Pressure in the Elderly Trial

  1986cited by this paper
• Effect of vasodilators on survival in chronic congestive heart failure.

  1985cited by this paper
• Cimetidine-induced liver injury. Report of three cases.

  1985cited by this paper
• Cumulating quality of life results in controlled trials of coronary artery bypass graft surgery.

  1985cited by this paper
• Mortality and morbidity results from the European Working Party on High Blood Pressure in the Elderly trial.

  1985cited by this paper
• Death of a volunteer.

  1985cited by this paper
• The Detection of New Adverse Drug Reactions

  1985cited by this paper
• Why less severe degrees of hypertension should be treated.

  1985cited by this paper
• Premarketing observational studies of population pharmacokinetics of new drugs

  1985cited by this paper
• Mild hypertension: treat patients, not populations.

  1985cited by this paper
• How Dangerous Are Diuretics?

  1985cited by this paper
• [Drug monitoring].

  1985cited by this paper
• MRC trial of treatment of mild hypertension: principal results. Medical Research Council Working Party.

  1985cited by this paper
• Piroxicam (Feldene) predisposes to chemotherapy-induced acute uric acid nephropathy.

  1984cited by this paper
• Current Status of Disease-Modifying Drugs in Progressive Rheumatoid Arthritis

  1984cited by this paper
• Ticrynafen‐Associated Hepatic Injury: Analysis of 340 Cases

  1984cited by this paper
• Diuretic-Induced Hypokalaemia and Ventricular Arrhythmias

  1984cited by this paper
• Approaches to the long-term treatment of duodenal ulcer disease.

  1984cited by this paper
• Post-marketing studies of drug efficacy: how?

  1984cited by this paper
• Review of peptic ulcer maintenance trials.

  1984cited by this paper
• Sudden Death in Men with Increased Risk of Myocardial Infarction

  1984cited by this paper
• Important Considerations for the Clinical Evaluation of Drugs: Appropriate Dosing Regimens

  1984cited by this paper
• Diuretics and Arrhythmias in the Medical Research Council Trial

  1984cited by this paper
• Trial on control of hypertension by nutritional means: three-year results.

  1984cited by this paper
• The Australian therapeutic trial in mild hypertension.

  1984cited by this paper
• Post-marketing studies of drug efficacy: why?

  1984cited by this paper
• Approaches to the long-term treatment of duodenal ulcer disease.

  1984cited by this paper
• Measuring functional outcomes in therapeutic trials for chronic disease.

  1984cited by this paper
• Vasodilator therapy of heart failure. Has the promissory note been paid?

  1984cited by this paper
• Survival in men with severe chronic left ventricular failure due to either coronary heart disease or idiopathic dilated cardiomyopathy.

  1983cited by this paper
• Vasodilator Therapy in Chronic Congestive Heart Failure

  1983cited by this paper
• The Effects of Digitalis on Survival in High‐risk Patients with Coronary Artery Disease: The Coronary Artery Surgery Study (CASS)

  1983cited by this paper
• Vasodilator therapy for acute myocardial infarction and chronic congestive heart failure.

  1983cited by this paper
• The Evaluation of Subjective Well-Being

  1983cited by this paper
• The role of toxicology in drug research and development

  1983cited by this paper
• Measuring and analysing quality of life in cancer clinical trials: a review.

  1983cited by this paper
• Prior thiazide diuretic treatment increases adrenaline-induced hypokalaemia.

  1983cited by this paper
• Coronary artery surgery study (CASS): a randomized trial of coronary artery bypass surgery. Quality of life in patients randomly assigned to treatment groups.

  1983cited by this paper
• Methodologic approach to adverse events applied to bupropion clinical trials.

  1983cited by this paper
• Remission-inducing therapy in rheumatoid arthritis.

  1983cited by this paper
• Why still prescribe chloramphenicol in 1983?

  1983cited by this paper
• Drug prescribing in renal failure: dosing guidelines for adults.

  1983cited by this paper
• N-acetyl-beta-glucosaminidase and beta 2-microglobulin. Their urinary excretion in patients with renal parenchymal disease.

  1983cited by this paper
• Approaches to rheumatoid arthritis and osteoarthritis: an overview.

  1983cited by this paper
• Ventricular extrasystoles during thiazide treatment: substudy of MRC mild hypertension trial.

  1983cited by this paper
• Mianserin and convulsive seizures.

  1983cited by this paper
• [Hepatic lesions associated with antimicrosomal antibodies of the liver and kidney (type 2) and the taking of tienilic acid. A study of 37 cases].

  1983cited by this paper
• Hematologic effects of antipyretic analgesics. Drug-induced agranulocytosis.

  1983cited by this paper
• Upper gastrointestinal hemorrhage.

  1983cited by this paper
• Incidence of seizures during treatment with tricyclic antidepressant drugs and bupropion.

  1983cited by this paper
• Hyperkalaemia in patients in hospital.

  1983cited by this paper
• Diuretics and digitalis in the treatment of chronic heart failure.

  1983cited by this paper
• Does drug therapy slow radiographic deterioration in rheumatoid arthritis?

  1983cited by this paper
• Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 3-1983. A 60-year-old man with progressive confusion, hypernatremia, and abdominal pain.

  1983cited by this paper
• Documenting suspected drug-induced thrombocytopenia.

  1983cited by this paper
• Quality of Life in Hypertensive Patients

  1982cited by this paper
• Jaundice associated with the use of benoxaprofen.

  1982cited by this paper
• The effect of hypotensive drugs on the quality of life.

  1982cited by this paper
• The pharmacokinetics of benoxaprofen in elderly subjects.

  1982cited by this paper
• Should Mild Hypertension Be Treated?

  1982cited by this paper
• Untreated mild hypertension. A report by the Management Committee of the Australian Therapeutic Trial in Mild Hypertension.

  1982cited by this paper
• Our national obsession with potassium.

  1982cited by this paper
• Is digoxin really important in treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm.

  1982cited by this paper
• The effect of treatment on mortality in "mild" hypertension: results of the hypertension detection and follow-up program.

  1982cited by this paper
• PHARMACOKINETIC STUDIES: THEIR ROLE IN DETERMINING THERAPEUTIC EFFICACY OF AGENTS DESIGNED TO PREVENT SUDDEN DEATH *

  1982cited by this paper
• Sounding board. Should mild hypertension be treated?

  1982cited by this paper
• Heart failure in outpatients: a randomized trial of digoxin versus placebo.

  1982cited by this paper
• Digitalis‐associated Cardiac Mortality After Myocardial Infarction

  1981cited by this paper
• Toxicology screening in small animals.

  1981cited by this paper
• Post-marketing surveillance: how many patients?

  1981cited by this paper
• Long‐term Vasodilator Therapy for Heart Failure: Clinical Response and its Relationship to Hemodynamic Measurements

  1981cited by this paper
• Dissatisfied patients

  1981cited by this paper
• Evidence for a circulating sodium transport inhibitor in essential hypertension.

  1981cited by this paper
• State of the Art Review: Does it Matter How Blood Pressure is Reduced?

  1981cited by this paper
• Hyponatraemia: mechanisms and management.

  1981cited by this paper
• The national ASGE survey on upper gastrointestinal bleeding. II. Clinical prognostic factors.

  1981cited by this paper
• Innovation and evaluation.

  1981cited by this paper
• Adverse reactions to bendrofluazide and propranolol for the treatment of mild hypertension. Report of Medical Research Council Working Party on Mild to Moderate Hypertension.

  1981cited by this paper
• Five to eight-year follow-up of patients undergoing porcine heart-valve replacement.

  1981cited by this paper
• Diuretic-induced ventricular ectopic activity.

  1981cited by this paper
• Bias in the elucidation of subjective side-effects.

  1981cited by this paper
• Blood tests for the diagnosis of venous and arterial thrombosis.

  1981cited by this paper
• Five year follow-up of effects of treatment of mild and moderate hypertension.

  1981cited by this paper
• Inheritance of abnormal erythrocyte cation transport in essential hypertension.

  1981cited by this paper
• Beneficial Effects of Afterload Reduction Therapy in Patients with Congestive Heart Failure and Moderate Aortic Stenosis

  1980cited by this paper
• Pharmacokinetic studies of propoxyphene I:Effect of portacaval shunt on systemic availability in dogs.

  1980cited by this paper
• The Australian therapeutic trial in mild hypertension. Report by the Management Committee.

  1980cited by this paper
• Do drugs change the course of rheumatoid arthritis?

  1980cited by this paper
• Treatment of mild hypertension: a five year controlled drug trial. The Oslo study.

  1980cited by this paper
• Dyspnoea, disability and distance walked: Comparison of estimates of exercise performance in respiratory disease

  1980cited by this paper
• Long-term safety of zomepirac: a double-blind comparison with aspirin in patients with osteoarthritis.

  1980cited by this paper
• Assessment of Drugs' Side Effects: Visual Analogue Scale versus Check-List Format

  1980cited by this paper
• Sustained effectiveness of converting-enzyme inhibition in patients with severe congestive heart failure.

  1980cited by this paper
• Inherited defect in a Na+, K+ -co-transport system in erythrocytes from essential hypertensive patients

  1980cited by this paper
• A NEW METHOD FOR STUDYING THE RELATIONSHIP BETWEEN HEPATIC UPTAKE OF DRUGS AND THEIR PHARMACODYNAMIC EFFECTS IN ANAESTHETIZED CATS

  1980cited by this paper

• Discrete Choice Experiment (DCE) as a Tool to Elicit Patient Preferences in a Complex Benefit–Risk Evaluation: A Case Study

  2026cites this paper
• Benefit–risk evaluation: the past, present and future

  2019cites this paper
• Regulatory Decision‐Making in the United States Based on a Single Pivotal Clinical Study: Principles and Precedents

  2004cites this paper
• Benefit‐risk analysis: a proposal using quantitative methods

  2003cites this paper
• [Evaluation of the therapeutic risk].

  1996cites this paper
• Rating Scales for Adverse Drug Reactions

  1993cites this paper
• The Way Towards Adverse Event Monitoring in Clinical Trials

  1993cites this paper
• Risk/Benefit Assessment: The “Greased Pig” of Drug Development

  1993cites this paper
• Risk/Benefit Assessment of New Drugs: Perspectives of a Former FDA Advisory Committee Member

  1993cites this paper
• Pitfalls in the Drug Approval Process: Dose-Effect, Experimental Design, and Risk-Benefit Issues

  1992cites this paper
• A Method for the Detection and Management of Adverse Events in Clinical Trials

  1991cites this paper
• Using Early Drug Development Data to Design Phase III Trials

  1991cites this paper
• Problems and benefits of an antibiotic compassionate therapy program.

  1987cites this paper